Results 111 to 120 of about 17,963 (297)

Microprolactinoma Growth During Pregnancy With Pituitary Tumor Apoplexy: Case Report and Review of the Literature

open access: yesCase Reports in Endocrinology, Volume 2025, Issue 1, 2025.
Prolactinomas are the most prevalent subtype of pituitary adenomas and represent one of the leading etiological factors responsible for amenorrhea and infertility in women. The primary therapeutic approach entails the use of dopamine agonists, which effectively restore fertility.
Lucia Introini   +5 more
wiley   +1 more source

Proteomic analysis of prolactinoma cells by immuno-laser capture microdissection combined with online two-dimensional nano-scale liquid chromatography/mass spectrometry

open access: yesProteome Science, 2010
Background Pituitary adenomas, the third most common intracranial tumor, comprise nearly 16.7% of intracranial neoplasm and 25%-44% of pituitary adenomas are prolactinomas.
Chen Luping   +7 more
doaj   +1 more source

Premature pubarche as a first presentation of pituitary macroprolactinoma

open access: yesJournal of Research in Medical Sciences, 2020
Prolactinoma is a rare tumor of childhood. Clinical presentations of prolactinoma include amenorrhea, delayed puberty, and galactorrhea. For the first time, in this case, elevated prolactin levels were associated with unexpected premature pubarche.
Fatemeh Tabatabaei   +5 more
doaj   +1 more source

Chronic cluster headache and the pituitary gland [PDF]

open access: yes, 2016
Background: Cluster headache is classified as a primary headache by definition not caused by an underlying pathology. However, symptomatic cases of otherwise typical cluster headache have been reported.
DE PUE, ANNELIEN   +2 more
core   +1 more source

Giant Prolactinoma in Men: Clinical Features and Therapeutic Outcomes

open access: yesHormone and Metabolic Research, 2018
The aim of the study was to evaluate the clinical features and long-term therapeutic outcome of giant prolactinoma (gPRLoma) in men and to compare them with those of a group of male patients with non-gPRL macroprolactinomas (non-gPRLomas).
P. Iglesias   +5 more
semanticscholar   +1 more source

Excellent response to pasireotide therapy in an aggressive and dopamine-resistant prolactinoma - commentary.

open access: yesEuropean Journal of Endocrinology, 2019
Recent publications suggested that pasireotide could be a good therapeutic option in some dopamine resistant or aggressive prolactinomas. We discussed the 2 published cases and describe another case of poorly-differentiated plurihormonal PIT-1 positive ...
G. Raverot   +3 more
semanticscholar   +1 more source

A study on the correlations of PRL levels with anxiety, depression, sleep, and self-efficacy in patients with prolactinoma

open access: yesFrontiers in Endocrinology
PurposeThe purpose of this study was to explore the factors influencing PRL levels in patients with prolactinoma and to investigate the correlations between anxiety, depression, sleep, self-efficacy, and PRL levels.MethodsThis retrospective study ...
Xiaoju Miao   +14 more
doaj   +1 more source

Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists [PDF]

open access: yes, 2018
Despite the fact that consensus guidelines recommend long-term dopamine agonist (DA) therapy as a first-line approach to the treatment of small prolactinoma, some patients continue to prefer a primary surgical approach.
Andres, Robert   +4 more
core  

Hormonal control of pituitary adenomas by transsphenoidal surgery: results of the first five years of experience [PDF]

open access: yes, 2011
OBJETIVO: Avaliar os resultados iniciais de uma equipe cirúrgica no controle hormonal dos adenomas hipofisários secretores. MATERIAIS E MÉTODOS: Em cinco anos, foram operados 51 adenomas secretores (31 GH, 14 ACTH, 5 prolactina, 1 TSH).
ABUCHAM, Julio   +4 more
core   +3 more sources

A Novel Case of Spontaneous Coronary Artery Dissection During Cabergoline Therapy for Prolactinoma

open access: yesJACC: Case Reports, 2020
We present a case of spontaneous coronary artery dissection associated with cabergoline treatment for prolactinoma. A 31-year-old woman with history of hypertension and prolactinoma, treated with cabergoline, presented with chest pain.
Shinichiro Ikeda, MD   +3 more
doaj  

Home - About - Disclaimer - Privacy